🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/04/2008 | 44,11 | 44,72 | 43,62 | 44,20 | -0,02% | 2,49% | 525.400 |
| 01/04/2008 | 43,61 | 44,67 | 43,42 | 44,21 | +1,97% | 2,85% | 751.800 |
| 31/03/2008 | 43,14 | 43,89 | 42,98 | 43,35 | +0,24% | 2,12% | 567.200 |
| 28/03/2008 | 44,36 | 44,62 | 42,97 | 43,25 | -2,26% | 3,72% | 679.800 |
| 27/03/2008 | 43,73 | 44,81 | 43,70 | 44,25 | +1,32% | 2,54% | 996.600 |
| 26/03/2008 | 41,93 | 44,05 | 41,93 | 43,67 | +3,40% | 5,07% | 1.844.200 |
| 25/03/2008 | 42,78 | 43,07 | 41,31 | 42,24 | -0,91% | 4,13% | 1.246.800 |
| 24/03/2008 | 41,93 | 43,38 | 41,61 | 42,63 | +2,27% | 4,21% | 1.757.200 |
| 20/03/2008 | 41,76 | 42,33 | 40,18 | 41,68 | +0,69% | 5,15% | 2.382.200 |
| 19/03/2008 | 40,89 | 42,24 | 40,72 | 41,40 | +1,91% | 3,72% | 2.572.600 |
| 18/03/2008 | 39,01 | 40,72 | 38,84 | 40,62 | +4,84% | 4,83% | 1.420.800 |
| 17/03/2008 | 38,84 | 39,63 | 38,51 | 38,75 | -1,67% | 2,90% | 926.600 |
| 14/03/2008 | 39,98 | 40,15 | 38,73 | 39,41 | -0,42% | 3,56% | 1.464.200 |
| 13/03/2008 | 38,93 | 40,27 | 38,66 | 39,57 | +1,05% | 4,14% | 1.437.200 |
| 12/03/2008 | 38,38 | 40,00 | 37,90 | 39,16 | +1,77% | 5,48% | 1.472.200 |
| 11/03/2008 | 38,26 | 38,53 | 37,44 | 38,48 | +2,89% | 2,85% | 1.633.800 |
| 10/03/2008 | 39,35 | 39,35 | 36,28 | 37,40 | -4,52% | 7,81% | 2.557.800 |
| 07/03/2008 | 40,00 | 40,47 | 39,04 | 39,17 | -2,53% | 3,56% | 1.197.400 |
| 06/03/2008 | 41,07 | 41,60 | 40,17 | 40,19 | -2,84% | 3,49% | 1.145.600 |
| 05/03/2008 | 41,97 | 41,99 | 40,87 | 41,36 | +0,17% | 2,67% | 671.800 |
| 04/03/2008 | 41,19 | 42,23 | 40,97 | 41,29 | -1,02% | 3,05% | 1.121.800 |
| 03/03/2008 | 42,03 | 42,50 | 41,28 | 41,72 | -0,88% | 2,90% | 1.076.400 |
| 29/02/2008 | 42,60 | 42,60 | 41,56 | 42,09 | +0,27% | 2,44% | 1.167.600 |
| 28/02/2008 | 42,00 | 42,61 | 41,82 | 41,97 | -0,19% | 1,87% | 552.200 |
| 27/02/2008 | 42,43 | 42,77 | 41,74 | 42,05 | -0,93% | 2,43% | 873.000 |
| 26/02/2008 | 41,59 | 42,85 | 41,59 | 42,45 | +1,40% | 3,02% | 1.139.000 |
| 25/02/2008 | 41,23 | 42,23 | 41,21 | 41,86 | +2,12% | 2,47% | 1.103.400 |
| 22/02/2008 | 41,52 | 41,68 | 40,11 | 40,99 | -0,92% | 3,78% | 1.904.200 |
| 21/02/2008 | 42,60 | 42,60 | 40,30 | 41,37 | -2,58% | 5,41% | 3.150.200 |
| 20/02/2008 | 43,73 | 44,11 | 42,45 | 42,47 | -3,36% | 3,81% | 1.777.800 |